Myrbetriq
Product formulated to relieve overactive bladder symptoms and designed to support bladder control by relaxing the bladder muscle.
- Category
- Bladder Health
- Active ingredient
- Mirabegron
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Prolonged-release tablet
- Strengths
- 50mg
Myrbetriq details
- Condition
- Overactive Bladder
- Alternative names
- Betmiga
- Therapeutic class
- Beta-3 Adrenoceptor Agonist
- Pharmacological class
- Beta-3 Adrenoceptor Agonist
- Contraindications
- hypersensitivity; severe uncontrolled hypertension
- Minor side effects
- tachycardia; urinary tract infection; nausea; headache
- Moderate side effects
- hypertension; dyspepsia; constipation
- Dosage forms
- Prolonged-release tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Astellas
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store at room temperature, away from excessive heat and moisture.
- Drug interactions
- metoprolol; digoxin; flecainide; propafenone
- Age restrictions
- Not recommended for children or adolescents.
- Pregnancy and breastfeeding
- Pregnancy: Avoid. Breastfeeding: Avoid.
Precautions and warnings
monitor blood pressure; use with caution in severe renal impairment; use with caution in hepatic impairment
Serious side effects
angioedema, requires immediate medical attention; urinary retention, requires immediate medical attention; atrial fibrillation, requires immediate medical attention
Patient summary
Product formulated to relieve overactive bladder symptoms and designed to support bladder control by relaxing the bladder muscle.
Mechanism of action
This medicine activates beta-3 adrenergic receptors in the bladder, which helps the bladder relax and increase its capacity to hold urine, preventing frequent contraction.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Myrbetriq
Myrbetriq is a branded medication containing the active ingredient mirabegron, which is commonly used to treat symptoms associated with an overactive bladder. This medication is also sold under the name Betmiga in various regions. Produced by Astellas, it is supplied as a tablet in the 50mg strength.
Buying Myrbetriq online
Myrbetriq is registered across 13 markets including Thailand, Malaysia and the Philippines, with availability also in Indonesia, Taiwan and South Korea. It is one of the most ordered medications for an overactive bladder across the region and can be purchased online. For many expats and those residing far from a major pharmacy, generic mirabegron, much of it made in India, provides a far more affordable option than the original Astellas brand.